Syncom Formulations (India) Ltd. Fundamental & Technical Research, Share Price Today

NSE : SYNCOMF

About Company

Syncom Formulations (India) Ltd. is engaged in the business of pharmaceutical formulations. The company manufactures range of products in various dosage forms and markets them in various countries. In addition to pharmaceutical formulations in the form of tablets, capsules, liquids and dry powders, the company also manufactures Injectibles, inhalers and ear/eye drops.The product range of the company includes Generic-Tablets,Capsules,Liquid Orals,Vials,Eye / Ear Drops,Ampoules and Dry Powder Orals.Herbal Branded-Colo Vaporex,Colo Inhaler,Colo Mouth Gel,Fastac Ointment,Candid Balm,Saloni Cream,Borosyn Cream,Edicare Cream,Ecziguard Cream,Pyl Gel,Attom Cream,Attom Megacaps,Shilajit Capsules,Liovset Tonic,Colo Cough Syrup,Pudin Rahat,Syncom Gripe Water,Feelax Powder and Yas Antacid Salt.Branded Allopathic-Qudermis Cream,Silver Plus Cream,Aciril Tablets,Fastac tablets,Odynil Tablets,Palera Plus Tablets,Polyfer Tablets 50 mg,Polyfer tablets 100 mg,Syncal D Tablets,M - Dox DT Tablets,Synortin Tablets,Synospas Tablets,Tici Forte Tablets,Triple Action Tablets,Flusa Kit Tablets,HBC kit (Combikit of 4 Tablets),NTB-4 Kit Tablets,Fresca Tablets,etc.

Market Cap. ₹ 1,608 Cr.

52 Week - High/Low ₹ 28/14

P/E Ratio 29.13

P/B Ratio 5.92

Enterprise Value ₹ 1,709 Cr.

ROE % 8.71

RSI Value 29.52

EMA 50 18.54

EMA 200 18.24

Market Cap. ₹ 1,608 Cr.

52 Week - High/Low ₹ 28/14

P/E Ratio 29.13

P/B Ratio 5.88

Enterprise Value ₹ 1,709 Cr.

ROE % 9.3

RSI Value 29.52

EMA 50 18.54

EMA 200 18.24

Add Parameters

Valuation

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages